Access Bio ranked among the top searched stocks for 3 days within the past month.


As of 10:30 AM on the 11th, Access Bio is trading at 23,950 KRW, up 0.84% from the previous day. This marks a 23.14% increase compared to December 4. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past 5 days, individual investors have net purchased 262,825 shares, while foreign investors and institutions have net sold 531,761 shares and net purchased 245,576 shares, respectively.


On December 8, Access Bio was a market topic for its "strong performance following a distribution contract for diagnostic kits with a US company."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing